Anyone crossing the land border from France into Spain will have to present a negative PCR taken in the last 72 hours, the Spanish government’s official bulletin said on Saturday.
The measure, which takes effect on Tuesday, comes as Spain ramps up restrictions in the hope it can avoid a surge in cases over Holy Week, which begins this weekend.
It is the first time such a requirement has been imposed on those crossing the land border between the two countries; until now, it has only been required of arrivals by air.
“They must have a PCR test (RT-PCR), a TMA test or another type of diagnostic test for SARS-CoV-2 based on equivalent molecular techniques, with a negative result, carried out in the 72 hours prior to arrival,” the bulletin said.
Only those working in transportation and cross-border workers will be exempt, along with those who live in the border zone as long as they remain within a 30-kilometre (18-mile) radius of their home.
Until mid-March, the number of infections had been steadily falling in Spain but has started to climb again, with government figures showing 7,586 new cases in 24 hours on Friday, raising the overall number to 3,255,324 and more than 75,000 deaths.
In France, however, daily cases have nearly doubled since the start of the month, reaching over 45,000 on Thursday, raising the overall number around 4,466,000 with more than 93,000 deaths.
With its bars and restaurants open and 11:00 pm curfew, Madrid has become a sought-after destination for leisure-starved Europeans, particularly those from France.
But the reality has angered Spaniards, who have been subjected to tight internal travel restrictions for months preventing them from leaving their own regions.
The ban has caused particular upset over Holy Week, a hugely popular holiday when people routinely travel to see family.
Follow the latest news on the coronavirus (COVID-19) outbreak
© 2021 AFP
Spain to require negative PCR at French land border (2021, March 27)
retrieved 27 March 2021
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022